Tag: editing

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...

Stardock reforges and integrates War of Magic, Fallen Enchantress and Sorcerer King to fulfill the original vision for Elemental PLYMOUTH, Mich., July 25, 2025 /PRNewswire/ --...

New toolkit streamlines one-click content creation in cloud-native space TOKYO, July 25, 2025 /PRNewswire/ -- TeraBox ("TeraBox" or "the Company"), a globally trusted cloud storage service...

New toolkit streamlines one-click content creation in cloud-native space TOKYO, July 25, 2025 /PRNewswire/ -- TeraBox ("TeraBox" or "the Company"), a globally trusted cloud storage service...

HONG KONG, July 25, 2025 /PRNewswire/ -- Infinix today unveiled its latest HOT 60 Series lineup, including the HOT 60 Pro+, HOT 60 Pro, HOT...

HONG KONG, July 25, 2025 /PRNewswire/ -- Infinix today unveiled its latest HOT 60 Series lineup, including the HOT 60 Pro+, HOT 60 Pro, HOT...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global CRISPR Gene Editing Market size & share revenue was valued at approximately USD 3.65 Billion in 2024 and is expected to reach USD 4.10 Billion in 2025 and is expected to reach around USD 12.6 Billion by 2034, at a CAGR of 13.01% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are CRISPR Therapeutics AG, Agilent Technologies Inc., Thermo Fisher Scientific Inc., GeneCopoeia Inc., Synthego Corporation, System Biosciences LLC, ToolGen Inc., Rockland Immunochemicals Inc., Horizon Discovery Group PLC, Abcam Inc., Applied StemCell Inc., Cellecta Inc and others.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global CRISPR Gene Editing Market size & share revenue was valued at approximately USD 3.65 Billion in 2024 and is expected to reach USD 4.10 Billion in 2025 and is expected to reach around USD 12.6 Billion by 2034, at a CAGR of 13.01% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are CRISPR Therapeutics AG, Agilent Technologies Inc., Thermo Fisher Scientific Inc., GeneCopoeia Inc., Synthego Corporation, System Biosciences LLC, ToolGen Inc., Rockland Immunochemicals Inc., Horizon Discovery Group PLC, Abcam Inc., Applied StemCell Inc., Cellecta Inc and others.

My partner’s hooked on those short English soap operas flooding his social feeds. They're full of basic plots, over-the-top acting, and good-looking actors. Yet,...

Online Tool Offers Retail and Hospitality Businesses Insight for Saving Money, Paper and Time LOS ALAMITOS, Calif., July 24, 2025 /PRNewswire/ -- As businesses look...

NEW YORK and TOKYO, July 23, 2025 /PRNewswire/ -- TNL Mediagene (Nasdaq: TNMG) (the "Company"), a Tokyo-based next-generation digital media and data group in...

ACM President Yannis Ioannidis and SIGGRAPH 2025 Conference Chair Ginger Alford Reflect on the Evolving Partnership Driving AI-Powered Breakthroughs in Graphics and Interactive Technology. NEW...

Next-Gen Solution Combines User-Friendly Spreadsheet Interface with Live Oracle Data, With a Time Savings of Up to 35% on Data Analysis Tasks ALPHARETTA, Ga., July...

Additional world-leading expertise stands to further accelerate the Company’s pipeline programs targeting rare neurodegenerative diseases

Additional world-leading expertise stands to further accelerate the Company’s pipeline programs targeting rare neurodegenerative diseases